Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Sacroiliac joint fusion
Sacroiliac joint fusion is a surgical treatment sometimes used to address pain that may be originating from the joint between bones in the spine and hip (sacrum and ilium). The sacroiliac joint (SIJ) is a diarthrodial joint with two surfaces and a fibrous capsule containing synovial fluid.
Sacroiliac joint fusion was first reviewed by the HTA program in 2019.
- In 2020, a review of sacroiliac joint fusion medical literature was conducted to determine if newly available published evidence could change the original coverage determination.
- In 2021, the HCA director selected sacroiliac joint fusion for rereview based on newly available published evidence that could change the original coverage determination.
Status: Decision completed
Why is sacroiliac joint fusion being reviewed?
The Washington Health Technology Assessment program (HTA) selected Sacroiliac joint fusion as a topic for assessment because of high concerns for safety, efficacy and cost.
Primary criteria ranking
- Safety = High
- Efficacy = High
- Cost = High
Documentation
| Type | Materials |
|---|---|
| Assessment (2021) | |
| Update literature (2020) | |
| Assessment (2019) |
Assessment timeline
-
Draft key questions published: January 26, 2021
-
Public comment period: January 26 to February 11, 2021
-
-
Final key questions published: February 25, 2021
-
Draft report published: April 2, 2021
-
Public comment period: April 2 to May 3, 2021
-
-
Final report published: May 19, 2021
-
HTCC public meeting: June 18, 2021